Friday, August 28, 2020

Johnson & Johnson's Janssen to begin Phase II COVID-19 vaccine trials next week in Spain

The trial will last two months and include 590 participants across the three countries, including 190 people in Spain, Illa told a news conference in Madrid.

from Economic Times https://ift.tt/2YK4tfz

No comments:

Post a Comment

In a sign of turnaround, over 200 smallcaps log double-digit weekly gains. Will the momentum continue?

Following a challenging February for smallcap stocks, the first week of March showed signs of recovery with over 200 smallcap names seeing d...